Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate Cancer
出版年份 2021 全文链接
标题
Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate Cancer
作者
关键词
-
出版物
Cancers
Volume 13, Issue 14, Pages 3607
出版商
MDPI AG
发表日期
2021-07-19
DOI
10.3390/cancers13143607
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development
- (2021) Hisham F. Bahmad et al. Frontiers in Genetics
- Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients
- (2021) Katalin Balázs et al. Journal of Personalized Medicine
- Investigating PSMA-targeted radioligand therapy efficacy as a function of cellular PSMA levels and intra-tumoral PSMA heterogeneity
- (2020) Kyle Current et al. CLINICAL CANCER RESEARCH
- NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy
- (2020) Thomas A. Hope et al. JOURNAL OF NUCLEAR MEDICINE
- Radiomics prediction model for the improved diagnosis of clinically significant prostate cancer on biparametric MRI
- (2020) Mengjuan Li et al. Quantitative Imaging in Medicine and Surgery
- Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
- (2020) Manuel Weber et al. BMC CANCER
- Mechanistic Insights for Optimizing PSMA Radioligand Therapy
- (2020) Aravind S. Ravi Kumar et al. CLINICAL CANCER RESEARCH
- Response and outcome of liver metastases in patients with metastatic castration-resistant prostate cancer (mCRPC) undergoing 177Lu-PSMA-617 radioligand therapy
- (2020) Fadi Khreish et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy
- (2020) Gu‐mu‐yang Zhang et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters
- (2020) Piotr Woźnicki et al. Cancers
- Magnetic resonance imaging radiomic analysis can preoperatively predict G1 and G2/3 grades in patients with NF-pNETs
- (2020) Yun Bian et al. Abdominal Radiology
- Radiomics Analysis Based on Diffusion Kurtosis Imaging and T2 Weighted Imaging for Differentiation of Pancreatic Neuroendocrine Tumors From Solid Pseudopapillary Tumors
- (2020) Yan-Jie Shi et al. Frontiers in Oncology
- Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors
- (2019) Clarisse Dromain et al. BMC CANCER
- Pancreatic neuroendocrine tumor: prediction of the tumor grade using magnetic resonance imaging findings and texture analysis with 3-T magnetic resonance
- (2019) Chuan-gen Guo et al. Cancer Management and Research
- Using biparametric MRI radiomics signature to differentiate between benign and malignant prostate lesions
- (2019) Min Xu et al. EUROPEAN JOURNAL OF RADIOLOGY
- FAPI-PET/CT: Mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer
- (2019) Clemens Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study
- (2019) Dongsheng Gu et al. EUROPEAN RADIOLOGY
- Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
- (2019) Alec Paschalis et al. EUROPEAN UROLOGY
- Preoperative Prediction of Extracapsular Extension: Radiomics Signature Based on Magnetic Resonance Imaging to Stage Prostate Cancer
- (2019) Shuai Ma et al. MOLECULAR IMAGING AND BIOLOGY
- Evolution of the Liquid Biopsy in Metastatic Prostate Cancer
- (2019) Jose G. Moreno et al. UROLOGY
- Molecular Imaging and Therapy for Neuroendocrine Tumors
- (2019) Hemant Desai et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE
- (2019) Josephine Graf et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The added value of intravoxel incoherent motion diffusion weighted imaging parameters in differentiating high‑grade pancreatic neuroendocrine neoplasms from pancreatic ductal adenocarcinoma
- (2019) Wanling Ma et al. Oncology Letters
- A Radiogenomic Approach for Decoding Molecular Mechanisms Underlying Tumor Progression in Prostate Cancer
- (2019) Fischer et al. Cancers
- The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research
- (2019) Eline A.M. Ruigrok et al. Pharmaceutics
- Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis
- (2018) Rodrigo Canellas et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy
- (2018) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer
- (2018) Christian Schmidkonz et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Targeting fibroblast activation protein in cancer ndash Prospects and caveats
- (2018) Aleksi Sedo Frontiers in Bioscience-Landmark
- Radiomics in Nuclear Medicine applied to Radiation Therapy: methods, pitfalls and challenges
- (2018) Sylvain Reuzé et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings
- (2018) Rakesh Shiradkar et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- [ 177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
- (2018) Michael S Hofman et al. LANCET ONCOLOGY
- The Heterogeneity of Prostate Cancer: A Practical Approach
- (2018) Yuri Tolkach et al. PATHOBIOLOGY
- Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
- (2018) Dirk Walter et al. Scientific Reports
- The NETest
- (2018) Irvin M. Modlin et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Role of textural heterogeneity parameters in patient selection for 177Lu-PSMA therapy via response prediction
- (2018) Zain Khurshid et al. Oncotarget
- Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade
- (2018) Chuangen Guo et al. Abdominal Radiology
- A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors
- (2018) Wenjie Liang et al. CLINICAL CANCER RESEARCH
- Inter- and intra-tumoral heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma
- (2018) Cindy Neuzillet et al. JOURNAL OF PATHOLOGY
- Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
- (2018) Katharina Lückerath et al. EJNMMI Research
- Neuroendocrine liver metastases: Vascular patterns on triple-phase MDCT are indicative of primary tumour location
- (2017) Maxime Ronot et al. EUROPEAN JOURNAL OF RADIOLOGY
- Tackling intra- and inter-tumor heterogeneity to combat triple negative breast cancer
- (2017) Ritu Aneja Frontiers in Bioscience-Landmark
- Liquid biopsy: a step forward towards precision medicine in urologic malignancies
- (2017) Ashley Di Meo et al. Molecular Cancer
- Intra-tumor heterogeneity from a cancer stem cell perspective
- (2017) Pramudita R. Prasetyanti et al. Molecular Cancer
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?
- (2017) Sonia Sahu et al. RADIOLOGY
- Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage
- (2017) Riccardo De Robertis et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors
- (2017) Elif Hindié Theranostics
- Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer
- (2017) Nikolas von Bubnoff Oncology Research and Treatment
- Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging
- (2016) Emad Lotfalizadeh et al. EUROPEAN RADIOLOGY
- Haralick textural features onT2-weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer
- (2016) Khémara Gnep et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
- (2016) R. P. Baum et al. JOURNAL OF NUCLEAR MEDICINE
- NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive
- (2016) Marianne Pavel et al. NEUROENDOCRINOLOGY
- Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors
- (2016) Ummuhan Abdulrezzak et al. NUCLEAR MEDICINE COMMUNICATIONS
- GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells
- (2016) Meixiang Sang et al. Oncotarget
- Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
- (2016) Feifei Cheng et al. Oncotarget
- Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
- (2016) Radka Stoyanova et al. Oncotarget
- Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity
- (2016) Rudolf A. Werner et al. Oncotarget
- Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
- (2015) Nicholas McGranahan et al. CANCER CELL
- Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade
- (2015) Koji Takumi et al. EUROPEAN JOURNAL OF RADIOLOGY
- Consensus on biomarkers for neuroendocrine tumour disease
- (2015) Kjell Oberg et al. LANCET ONCOLOGY
- Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images
- (2015) Duc Fehr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
- (2014) J. P. B. O'Connor et al. CLINICAL CANCER RESEARCH
- Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade
- (2013) Jung Hoon Kim et al. ABDOMINAL IMAGING
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
- (2013) Joshua M Francis et al. NATURE GENETICS
- The Correlation between Apparent Diffusion Coefficient and Tumor Cellularity in Patients: A Meta-Analysis
- (2013) Lihua Chen et al. PLoS One
- High Sensitivity of Diffusion-weighted MR Imaging for the Detection of Liver Metastases from Neuroendocrine Tumors: Comparison with T2-weighted and Dynamic Gadolinium-enhanced MR Imaging
- (2013) Gaspard d’Assignies et al. RADIOLOGY
- Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors
- (2012) Maxime Palazzo et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- ENETS 2011 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update
- (2012) Ramon Salazar et al. NEUROENDOCRINOLOGY
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) K. Oberg et al. ANNALS OF ONCOLOGY
- Hepatic Metastases From Neuroendocrine Tumors With a “Thin Slice” Pathological Examination
- (2010) Dominique Elias et al. ANNALS OF SURGERY
- Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease
- (2010) Irvin M. Modlin et al. ANNALS OF SURGICAL ONCOLOGY
- Comparison of Biexponential and Monoexponential Model of Diffusion Weighted Imaging in Evaluation of Renal Lesions
- (2010) Hersh Chandarana et al. INVESTIGATIVE RADIOLOGY
- The North American Neuroendocrine Tumor Society (NANETS) Guidelines
- (2010) Larry K. Kvols et al. PANCREAS
- Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma
- (2009) Cosimo Durante et al. ENDOCRINE-RELATED CANCER
- Angiogenesis as a strategic target for prostate cancer therapy
- (2009) Yong Li et al. MEDICINAL RESEARCH REVIEWS
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
- (2009) Dermot O’Toole et al. NEUROENDOCRINOLOGY
- In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology
- (2009) Kuroda ONCOLOGY REPORTS
- Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer
- (2008) Miho I. Yoshikawa et al.
- Pancreatic Endocrine Tumors: Tumor Blood Flow Assessed with Perfusion CT Reflects Angiogenesis and Correlates with Prognostic Factors1
- (2008) Gaspard d'Assignies et al. RADIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started